摘要 |
Disclosed is a compound represented by the Structural Formula (I): Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both >C=Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or -C(R<SUB>7</SUB>R<SUB>8</SUB>)-. R<SUB>1 </SUB>and R<SUB>2 </SUB>are independently an aryl group or a substituted aryl group, R<SUB>3 </SUB>and R<SUB>4 </SUB>are independently -H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R<SUB>5</SUB>-R<SUB>6 </SUB>are independently -H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R<SUB>7 </SUB>and R<SUB>8 </SUB>are each independently -H, an aliphatic or substituted aliphatic group, or R<SUB>7 </SUB>is -H and R<SUB>8 </SUB>is a substituted or unsubstituted aryl group, or, R<SUB>7 </SUB>and R<SUB>8</SUB>, taken together, are a C2-C6 substituted or unsubstituted alkylene group. Z is -O or -S. Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject with cancer by administering to the subject a compound of Structural Formula (I) in combination with Paclitaxel or an analog of Paclitaxel.
|